Niehues Gabriela Danielski, Balan Alexandre Balestieri, Prá Vinicius Brum, Pellizzaro Raphaela Santos, da Silva Paulo Roberto Antunes, Niehues Manuela Danielski, Costa Ana Paula, Schwarzbold Marcelo Liborio, Diaz Alexandre Paim
Instituto de Psiquiatria de Santa Catarina (IPQ/SC), São José, SC, Brazil.
Faculdade de Medicina, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil.
Trends Psychiatry Psychother. 2017 Jul-Sep;39(3):158-164. doi: 10.1590/2237-6089-2016-0053. Epub 2017 Jul 31.
Clozapine is a well-recognized effective treatment for some patients with treatment-resistant schizophrenia (TRS). Although it has potential benefits and approximately 30% of patients have a clinical indication for clozapine use, prescription rates are low.
To evaluate clozapine prescription trends over a 5-year period in a tertiary psychiatric hospital.
In this observational study, data prospectively collected by the Medical and Statistical File Service (Serviço de Arquivo Médico e Estatístico) and the Pharmacy Division of Instituto de Psiquiatria de Santa Catarina between January 2010 and December 2014 were summarized and analyzed by investigators blinded to data collection. The number of 100 mg clozapine pills dispensed by the Pharmacy Division to the inpatient units was the outcome and considered a proxy measure of clozapine prescriptions. The number of occupied inpatient unit beds and the number of patients admitted with F20-F29 (ICD-10) diagnoses during the study period were considered to be possible confounders.
A multiple linear regression model showed that time in months was independently associated with an increase in the number of clozapine pills dispensed by the Pharmacy Division (β coefficient = 15.82; 95% confidence interval 10.88-20.75).
Clozapine prescriptions were found to have increased during the 5-year period studied, a trend that is opposite to reports from several other countries.
氯氮平是治疗某些难治性精神分裂症(TRS)患者的一种公认有效的药物。尽管它有潜在益处,约30%的患者有使用氯氮平的临床指征,但处方率却很低。
评估一家三级精神病医院5年期间氯氮平的处方趋势。
在这项观察性研究中,由圣卡塔琳娜精神病学研究所医学与统计档案服务部(Serviço de Arquivo Médico e Estatístico)和药房部门在2010年1月至2014年12月期间前瞻性收集的数据,由对数据收集不知情的研究人员进行汇总和分析。药房部门发放给住院病房的100毫克氯氮平药片数量为观察结果,并被视为氯氮平处方的替代指标。研究期间住院病房占用床位数量以及诊断为F20 - F29(国际疾病分类第十版)的入院患者数量被视为可能的混杂因素。
多元线性回归模型显示,以月为单位的时间与药房部门发放的氯氮平药片数量增加独立相关(β系数 = 15.82;95%置信区间10.88 - 20.75)。
在所研究的5年期间发现氯氮平处方有所增加,这一趋势与其他几个国家的报告相反。